These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8722328)
1. Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells. Bensinger WI; Buckner CD; Rowley S; Storb R; Appelbaum FR Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S19-21. PubMed ID: 8722328 [No Abstract] [Full Text] [Related]
2. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors. Corringham RE; Ho AD Blood; 1995 Sep; 86(5):2052-4. PubMed ID: 7544651 [No Abstract] [Full Text] [Related]
3. Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation. Negrin RS; Kusnierz-Glaz C; Blume KG; Strober S Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S31-3. PubMed ID: 8722331 [No Abstract] [Full Text] [Related]
4. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy. Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816 [TBL] [Abstract][Full Text] [Related]
10. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors. Akabutu JJ; Chan JR Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448 [No Abstract] [Full Text] [Related]
11. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Matsunaga T; Sakamaki S; Kohgo Y; Ohi S; Hirayama Y; Niitsu Y Bone Marrow Transplant; 1993 Feb; 11(2):103-8. PubMed ID: 7679596 [TBL] [Abstract][Full Text] [Related]
12. Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy. Bensinger WI; Buckner CD; Rowley S; Demirer T; Storb R; Appelbaum FA Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S38-9. PubMed ID: 8722333 [No Abstract] [Full Text] [Related]
13. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic peripheral blood progenitor cells: current status and future directions. Dreger P; Glass B; Uharek L; Schmitz N J Hematother; 1996 Aug; 5(4):331-7. PubMed ID: 8877708 [TBL] [Abstract][Full Text] [Related]